Study to Assess the Safety and Effectiveness of Novel Radiopharmaceutical Terbium-161 DOTATATE in Metastatic Neuroendocrine Tumors

Clinical trial NCT07404176 · RECRUITING

Trial details

NCT number: NCT07404176
Sponsor: Tata Memorial Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Neoplasms (Tumours)Neuroendocrine Tumors Metastatic Neuroendocrine Tumors

Start date: 2026-03-01
Primary completion: 2028-02-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.